Yong Wang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 1%
- MicroRNA in disease regulation
Papers in
- Biomaterials 46
- Nanoparticle-Based Drug Delivery 44
-
- MicroRNA in disease regulation 25
- Co-authors
- Xintao Shuai (52 shared papers)Robert R. Rando (2 shared papers)Hong Ping Xiao (15 shared papers)Du Cheng (9 shared papers)Daohong Zhou (5 shared papers)Zecong Xiao (12 shared papers)Shisong Han (7 shared papers)Bo Li (13 shared papers)
- Journals
- PLoS ONE (5 papers)Blood (5 papers)Biomaterials Science (5 papers)Scientific Reports (4 papers)Journal of Controlled Release (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yong Wang
236 papers receiving 9.8k citations
Yong Wang's Hit Papers
Peers
Comparison fields: 5 of 141
- Biomaterials 1.3k
- Cancer Research 1.2k
- Drug Discovery 18
- Oncology 1.1k
- Aquatic Science 344
Countries citing papers authored by Yong Wang
This map shows the geographic impact of Yong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Wang more than expected).
Fields of papers citing papers by Yong Wang
This network shows the impact of papers produced by Yong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Wang. The network helps show where Yong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 537 | |
| 2 | 2011 | 505 | |
| 3 | 2005 | 334 | |
| 4 | Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2021 | 322 |
| 5 | 2009 | 248 | |
| 6 | Plasma microRNAs as novel biomarkers for early detection of lung cancer. | 2011 | 223 |
| 7 | 2009 | 218 | |
| 8 | 1995 | 199 | |
| 9 | 2014 | 198 | |
| 10 | 2020 | 195 | |
| 11 | 2020 | 193 | |
| 12 | 2021 | 191 | |
| 13 | 2020 | 170 | |
| 14 | Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways Hit paper breakdown → | 2020 | 168 |
| 15 | 2016 | 164 | |
| 16 | 2005 | 161 | |
| 17 | 2020 | 153 | |
| 18 | 1997 | 148 | |
| 19 | 2010 | 146 | |
| 20 | 2018 | 122 |
About Yong Wang
Yong Wang is a scholar working on Biomaterials, Cancer Research, Oncology, Immunology and Molecular Biology, having authored 243 papers that have together received 10k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (44 papers), MicroRNA in disease regulation (25 papers), Nanoplatforms for cancer theranostics (20 papers), RNA Interference and Gene Delivery (19 papers), Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Biomaterials (1.3k citations), Cancer Research (1.2k citations), Drug Discovery (18 citations), Oncology (1.1k citations) and Aquatic Science (344 citations). Yong Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xintao Shuai, Robert R. Rando, Hong Ping Xiao, Du Cheng, Daohong Zhou, Zecong Xiao, Shisong Han, Bo Li, Jingguo Li and Jinsheng Huang. Their work appears in journals such as PLoS ONE, Blood, Biomaterials Science, Scientific Reports and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.